Untitled Quiz
24 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the recommended ESC algorithm to measure high-sensitivity cardiac troponin?

  • 0h/2h in case h-FABP and copeptin as markers are available
  • 0h/3h
  • 0h/2h in case CK-MB is not available (correct)
  • 0h/1h or as an alternative, 0h/2h
  • Which of the following scores should be considered for prognosis estimation in CAD?

  • GRACE (correct)
  • CRUSADE
  • EUROSCORE
  • DAPT
  • In non-ST elevation acute coronary syndrome patients, when is routine antithrombotic pretreatment with a P2Y12 inhibitor indicated?

  • Only if the patient has a prior history of myocardial infarction
  • It is always indicated in intermediate-risk patients
  • When coronary anatomy is already known and invasive management is planned (correct)
  • In high-risk patients regardless of coronary anatomy
  • What condition indicates the need for an immediate invasive strategy in NSTE-ACS patients?

    <p>Very high risk NSTE-ACS irrespective of ECG</p> Signup and view all the answers

    When should an early invasive strategy (< 24 h) be warranted for NSTE-ACS patients?

    <p>For patients with dynamic ST segment changes</p> Signup and view all the answers

    Which approach should low-risk NSTE-ACS patients ideally follow?

    <p>Be discharged without further tests</p> Signup and view all the answers

    Which of the following statements regarding anticoagulation therapy in NSTE-ACS is correct?

    <p>Anticoagulation therapy is required if symptoms began less than 6 hours ago</p> Signup and view all the answers

    What factor is NOT considered when determining the urgency of treatment for NSTE-ACS patients?

    <p>Current medications the patient is on</p> Signup and view all the answers

    Which statement regarding the use of fibrinolytics is correct?

    <p>Fibrinolytic therapy is recommended if timely primary PCI cannot be performed.</p> Signup and view all the answers

    What is the preferred P2Y12 inhibitor for Acute coronary syndrome with ST segment elevation undergoing primary PCI?

    <p>Ticagrelor</p> Signup and view all the answers

    What is the maximum recommended time from successful fibrinolysis to coronary angiography for stable patients?

    <p>Within 24 hours</p> Signup and view all the answers

    Which antithrombotic agents are not indicated for the treatment of unstable angina?

    <p>Warfarin</p> Signup and view all the answers

    How long is dual antithrombotic therapy recommended after the acute myocardial infarction for a patient with sinus rhythm?

    <p>6 - 12 months</p> Signup and view all the answers

    Which drug is recommended for secondary prevention of recurrent cardiovascular events after acute anterior STEMI?

    <p>All of the above</p> Signup and view all the answers

    When should a Troponin test be repeated if the first one is negative in suspected Acute coronary syndrome without ST segment elevation?

    <p>After 3 hours</p> Signup and view all the answers

    Which criterion is NOT a typical indicator of myocardial infarction?

    <p>Hypercholesterolemia</p> Signup and view all the answers

    Which high-risk criteria indicates the need for an early invasive strategy within 24 hours in NSTE-ACS patients?

    <p>Diagnosis of NSTEMI suggested by the diagnostic algorithm</p> Signup and view all the answers

    Which of the following is NOT considered a criterion for type 1 myocardial infarction?

    <p>Positive stress ECG test</p> Signup and view all the answers

    Which of the following involves the medical treatment of coronary artery disease?

    <p>Coronary artery bypass surgery</p> Signup and view all the answers

    Which diagnostic tool is least effective at determining the location of myocardial damage?

    <p>Continuous glucose monitor</p> Signup and view all the answers

    What is the main purpose of thrombolytic therapy in patients with ST-segment elevation myocardial infarction (MI)?

    <p>To dissolve blood clots in coronary arteries</p> Signup and view all the answers

    In a patient who experienced a myocardial infarction, which complication is he most at risk for developing within a few days of the event?

    <p>Free wall rupture</p> Signup and view all the answers

    Which exclusion criteria must a patient meet for fibrinolytic therapy in STEMI cases?

    <p>Recent significant surgery</p> Signup and view all the answers

    Which of the following medications is likely to be part of the initial treatment for an ST-segment elevation myocardial infarction?

    <p>Antiplatelet agents</p> Signup and view all the answers

    Study Notes

    ECG and Biomarkers in ACS

    • ECG and CK-MB levels are helpful in diagnosing acute coronary syndrome (ACS).
    • High-sensitivity cardiac troponin (hs-cTn) and echocardiography are also used for diagnosis.
    • Symptoms and clinical history play a crucial role in diagnosis.

    ESC Algorithm for hs-cTn

    • According to ESC, hs-cTn should be measured at 0h and 2h for assessment of ACS.
    • This is recommended especially if CK-MB is not available.
    • 0h/1h measurement is also acceptable as an alternative.

    Prognostic Score for ACS

    • GRACE (Global Registry of Acute Coronary Events)
    • CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Aggressive Management)
    • DAPT (Dual Antiplatelet Therapy)
    • EUROSCORE (European System for Cardiac Operative Risk Evaluation)
    • ACUITY (Acute Coronary Treatment and Intervention Outcomes Network)

    P2Y12 Inhibitors in NSTE-ACS

    • Routine pre-treatment with P2Y12 inhibitors is not recommended for all NSTE-ACS patients.
    • It may be considered in patients with established Coronary Artery Disease (CAD) and prior Percutaneous Coronary Intervention (PCI).
    • It's recommended for high-risk NSTE-ACS patients.
    • It should be avoided in patients with advanced age due to increased bleeding risk.
    • If the symptom onset is > 6 hours, it may not be indicated.

    Timing of Invasive Strategy in NSTE-ACS

    • Immediate invasive strategy (< 2 hours from hospital admission) is recommended for:
      • Stabilized resuscitated out-of-hospital cardiac arrest
      • Very high-risk NSTE-ACS patients
      • NSTE-ACS patients with no contraindications to invasive treatment.
    • Early invasive strategy (< 24 hours of hospital admission) is recommended for:
      • Very high-risk NSTE-ACS patients irrespective of ECG or biomarker findings
      • Persistent chest pain
      • Life-threatening arrhythmias
      • Dynamic ST segment changes and/or GRACE risk score > 140.

    Management of Low-Risk NSTE-ACS

    • Low-risk NSTE-ACS patients should:
      • Be selectively scheduled for coronary angiography following a positive non-invasive test.
      • Undergo cardiac computer tomography angiography or coronary angiography according to their preferences.

    Fibrinolysis in STEMI

    • Fibrinolysis is indicated in patients with ST-segment elevation myocardial infarction (STEMI), especially when timely primary PCI cannot be performed.
    • Fibrin-specific agents are recommended.
    • Fibrinolysis should be performed within 30 minutes of STEMI diagnosis for optimal outcomes.

    Myocardial Infarction: Typical and High-Risk Criteria

    • Increased Troponin levels are the most typical criteria for myocardial infarction.
    • High-risk criteria for recurrent ischemia or cardiovascular death for NSTE-ACS include:
      • GRACE score > 140
      • Dynamic ST segment depressions on ECG
      • Established NSTEMI diagnosis
      • PCI within the last year

    Treatment of High-Risk NSTE-ACS

    • Percutaneous coronary intervention (PCI) is the preferred treatment for very high-risk NSTE-ACS patients.

    P2Y12 Inhibitors in STEMI

    • Prasugrel is recommended for patients with acute coronary syndrome with ST-segment elevation undergoing primary PCI strategy.

    Timing for Coronary Angiography after Fibrinolysis

    • Coronary angiography with secondary PCI within 24 hours is recommended for stable patients after successful fibrinolysis.

    Antithrombotic Agents in Unstable Angina

    • Warfarin is not indicated for unstable angina.

    Dual Antithrombotic Therapy after MI

    • Dual antithrombotic therapy for patients with sinus rhythm after acute myocardial infarction is recommended for:
      • 3 months if a stent is not implanted.
      • 6-12 months if a stent is implanted.

    Secondary Prevention after STEMI

    • Aspirin, beta-blockers, statins, and ACEI are all recommended for secondary prevention of recurrent cardiovascular events after acute anterior STEMI.

    Repeat Troponin Testing

    • If the initial Troponin test is negative for suspected NSTE-ACS, it should be repeated after 3 hours.

    Early Invasive Strategy in NSTE-ACS

    • Early invasive strategy (< 24 hours) is recommended for high-risk NSTE-ACS patients with:
      • Diagnosis of NSTEMI suggested by the diagnostic algorithm
      • Recurrent or refractory chest pain despite medical treatment
      • Dynamic or presumably new contiguous ST/T-segment changes suggesting ongoing ischemia
      • Heart failure clearly related to NSTE-ACS

    Universal Definition of Myocardial Infarction

    • Stress ECG test is NOT included in the universal definition of a type 1 myocardial infarction.

    Medical Management of Coronary Artery Disease

    • Medical management of CAD includes:
      • Oral medication administration
      • Cardiac catheterization
      • Percutaneous transluminal coronary angioplasty
      • Coronary artery bypass surgery

    Diagnostic Tools for Myocardial Damage

    • Cardiac catheterization is used to diagnose CAD and determine the location of myocardial damage.
    • Echocardiogram, electrocardiogram, and cardiac enzymes are also used to diagnose and assess the extent of myocardial damage.

    Diagnosis of CAD

    • Electrocardiogram (ECG) is used to diagnose CAD.
    • Treadmill stress test is another helpful diagnostic tool.
    • Cardiac catheterization is the most invasive and definitive method for confirming the diagnosis.

    Complication after MI

    • Left atrial thrombus is a common and serious complication in the first few days following a myocardial infarction.

    Fibrinolytic Therapy Exclusion Criteria

    • Exclusion criteria for receiving fibrinolytic therapy for STEMI:
      • Active internal bleeding within the last 21 days
      • Known bleeding disorder
      • Within 3 months of intracranial surgery, serious head trauma, or stroke
      • **Within 14 days of major surgery or serious trauma **
      • History of intracranial hemorrhage
    • Witnessed seizure at onset and history of cancer of the brain are not absolute exclusion criteria.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    More Like This

    Untitled Quiz
    6 questions

    Untitled Quiz

    AdoredHealing avatar
    AdoredHealing
    Untitled Quiz
    37 questions

    Untitled Quiz

    WellReceivedSquirrel7948 avatar
    WellReceivedSquirrel7948
    Untitled Quiz
    55 questions

    Untitled Quiz

    StatuesquePrimrose avatar
    StatuesquePrimrose
    Untitled Quiz
    18 questions

    Untitled Quiz

    RighteousIguana avatar
    RighteousIguana
    Use Quizgecko on...
    Browser
    Browser